Recursion Pharmaceuticals Inc - RXRX Market Value

Recursion Pharmaceuticals (RXRX) combines biological expertise with the power of neural networks, attracting top specialists through a culture of innovation. The company is actively scaling its digital drug discovery platform via alliances with tech giants. The business's environmental focus is evident in its minimization of laboratory waste and energy efficiency. Market capitalization stands at 2.00, which is clearly demonstrated by this price chart serving as the primary valuation tool.

RXRX (Recursion Pharmaceuticals) Market Capitalization history from 07/04/2022 to 11/11/2026

Analytical breakdowns for Recursion Pharmaceuticals

- stock price and consensus target price:

Stock Quotes Recursion|RXRX - Broker Consensus Forecast

- issuer market value details:

Market Value Recursion Corp|RXRX - Value Adjusted for Debt and Cash

- book value of equity indicators:

Accounting Value per Share Recursion|RXRX - Accounting Capitalization|Market Capitalization to Book Value Ratio recursion.com|RXRX - Company Total Assets

- debt and solvency information:

- net income and valuation multiples indicators:

RXRX - Net Profit|Expected Profit Recursion Pharmaceuticals|RXRX - Company Value to Net Income|Future Price to Earnings recursion.com|RXRX - Growth-Adjusted Market Cap to Net Income|EV/EBITDA Multiple Recursion Corp|RXRX - Operating income before deduction of amortization|Earnings per share for the last twelve months Recursion|RXRX - Net earnings per one share for the last twelve months|Year-over-year earnings per share growth for the last twelve months recursion.com|RXRX - Earnings per share growth this year|Expected earnings per share growth for next year Recursion Pharmaceuticals

Summary company analysis:Recursion Pharmaceuticals RXRX

Assessing business resilience to market volatility requires an analysis of the aggregate value of all shares, as reflected by the issuer's market capitalization. For Recursion Pharmaceuticals (RXRX), which is developing an AI platform for biomedical discoveries, this indicator measures market confidence in the scalability of its digital ecosystem, allowing investors to filter out short-term noise and objectively evaluate the company's fundamental value.

Competitor analysis